Source link : https://www.newshealth.biz/health-news/long-term-data-support-non-hormonal-drug-for-hot-flash-management/
CHICAGO — The non-hormonal drug elinzanetant reduced the frequency of moderate-to-severe hot flashes in postmenopausal women, and seemed to have a favorable safety profile, according to long-term OASIS 3 trial data. Women with moderate-to-severe vasomotor symptoms (VMS) treated with elinzanetant for 12 weeks had an average of 1.6 hot flashes per day compared to 3.4 […]
Author : News Health
Publish date : 2024-09-15 21:27:04
Copyright for syndicated content belongs to the linked Source.
Categories